County
Brigham City, Cache County, Logan City, Smithfield Fire Departments
Brigham City, Cache County, Logan City, Smithfield Fire Departments (UT) carries 33 drugs across 121 dose entries in its current published protocol, effective 2025-12-02.
Drugs and doses33
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 650–1000 mg | PO | not captured | standing | page 52 |
| Fever | adult | 650–1000 mg | IV | not captured | standing | page 52 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 52 |
| Fever | peds | 15 mg/kg | IV | not captured | standing | page 52 |
| Mild to moderate pain | adult | 500–1000 mg | IV/PO | not captured | standing | page 19 |
| Mild to moderate pain | peds | 15 mg/kg | IV/PO | not captured | standing | page 19 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | page 46 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | page 46 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 50 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 50 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | page 60 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | page 60 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 42 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 34 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 34 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324–325 mg | PO | not captured | standing | page 35 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 31 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 31 |
| Nerve agent exposure | adult | 2 mg | IV/IM | not captured | standing | page 73 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 34 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 34 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 34 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | page 34 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 54 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 54 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IO | not captured | standing | page 49 |
| Agitation | peds | 0.1 mg/kg (max 5 mg) | IV/IO | not captured | standing | page 49 |
| Agitation | peds | 0.2 mg/kg (max 10 mg) | IM | not captured | standing | page 49 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 63 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 63 |
| Seizure | peds | 0.1 mg/kg (max 5 mg) | IV/IO | not captured | standing | page 63 |
| Seizure | peds | 0.2 mg/kg (max 10 mg) | IM | not captured | standing | page 63 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 47 |
| Anaphylaxis | peds | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 47 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 46 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 46 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 33 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 33 |
| Hypotension / shock | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 26 |
| Respiratory distress | adult | 0.5 mg | IM | not captured | standing | page 61 |
| Respiratory distress | peds | 0.01 mg/kg | IM | not captured | standing | page 61 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | page 19 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 19 |
| Procedural sedation | adult | 50–100 mcg | IV | not captured | standing | page 23 |
| Procedural sedation | peds | 0.5 mcg/kg | IV | not captured | standing | page 23 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 54 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV/IO | not captured | standing | page 49 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 49 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Carbon monoxide poisoning | adult | 5 g | IV/IO | not captured | standing | page 68 |
| Carbon monoxide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 68 |
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 69 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 69 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 600 mg | PO | not captured | standing | page 52 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 52 |
| Mild to moderate pain | adult | 600 mg | PO | not captured | standing | page 19 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 19 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 61 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 61 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO | not captured | standing | page 49 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 49 |
| Mild to moderate pain | adult | 40 mg | IV/IO | not captured | standing | page 20 |
| Mild to moderate pain | peds | 0.15–0.3 mg/kg | IV/IO | not captured | standing | page 20 |
| Procedural sedation | adult | 100 mg | IV | not captured | standing | page 23 |
| Procedural sedation | peds | 1 mg/kg | IV | not captured | standing | page 23 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 19 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 19 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 19 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 19 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| VF / pulseless VT | adult | 1 mg/kg | IV/IO/ET | not captured | standing | page 34 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO/ET | not captured | standing | page 34 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO | not captured | standing | page 49 |
| Agitation | peds | 0.05 mg/kg (max 2 mg) | IV/IO | not captured | standing | page 49 |
| Agitation | peds | 0.05 mg/kg (max 4 mg) | IM | not captured | standing | page 49 |
| Seizure | adult | 4 mg | IV/IO/IM | not captured | standing | page 63 |
| Seizure | peds | 0.1 mg/kg (max 4 mg) | IV/IO/IM | not captured | standing | page 63 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 61 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | page 61 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV/IO/IM | not captured | standing | page 57 |
| Eclampsia / pre-eclampsia | peds | 5 g | IV/IO/IM | not captured | standing | page 57 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 34 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | page 34 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IO | not captured | standing | page 49 |
| Agitation | adult | 5 mg | IM/IN | not captured | standing | page 49 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 49 |
| Agitation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 49 |
| Procedural sedation | adult | 2.5 mg | IV | not captured | standing | page 23 |
| Procedural sedation | peds | 0.05 mg/kg | IV | not captured | standing | page 23 |
| Seizure | adult | 10 mg | IN | not captured | standing | page 63 |
| Seizure | adult | 2.5–5 mg | IV/IO | not captured | standing | page 63 |
| Seizure | adult | 5–10 mg | IM | not captured | standing | page 63 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 63 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 63 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 19 |
| Mild to moderate pain | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 19 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2–4 mg | IV/IO/IM/IN | not captured | standing | page 33 |
| Cardiac arrest | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 33 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | page 10 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | page 10 |
| Opioid overdose | adult | 2 mg | IM | not captured | standing | page 10 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 10 |
| Opioid overdose | peds | 0.1 mg/kg | IM | not captured | standing | page 10 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 10 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 35 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 37 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 26 |
| Hypotension / shock | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 26 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 17 |
| Nausea / vomiting | adult | 4–8 mg | IV/IM/PO | not captured | standing | page 17 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/PO | not captured | standing | page 17 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 53 |
| Hypoglycemia | peds | 7.5 g | PO | not captured | standing | page 53 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 55 |
| Obstetric hemorrhage | adult | 10 unit | IV/IO | not captured | standing | page 57 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IV | not captured | standing | page 17 |
| Nausea / vomiting | adult | 25 mg | IM | not captured | standing | page 17 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 34 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 34 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 59 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 57 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 82 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 82 |